MET and cancer: For this reason, Met-targeted cancer therapies have been developed and several HGF/Met inhibitors, including HGF neutralizing antibodies, Met down-regulating antibodies and Met Tyrosine Kinase Inhibitors (TKIs), are currently exploited in clinical trials [12].